Praxis Precision Medicines, Inc. (PRAX) vs Rhythm Pharmaceuticals, Inc. (RYTM)
- Praxis Precision Medicines, Inc. PRAX 241.76 −2.61%
- Rhythm Pharmaceuticals, Inc. RYTM 86.17 −2.05%
Praxis Precision Medicines, Inc. and Rhythm Pharmaceuticals, Inc. are both Biotechnology companies. Praxis Precision Medicines, Inc. is the larger, with a market value of $6.9B against $6.1B — 1.1× the size. Praxis Precision Medicines, Inc. grew revenue faster over the last twelve months: 249.5% against 53.5%. Praxis Precision Medicines, Inc. has the higher net margin (0.00% vs −87.6%) and the lower return on invested capital (−40.6% vs 0.00%). Across the 16 metrics below, Praxis Precision Medicines, Inc. leads on 10 and Rhythm Pharmaceuticals, Inc. on 6.
Valuation
Profitability
| Metric | PRAX | RYTM | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 89.00% | 65.16% |
| Operating margin | 0.00% | (83.62%) | 0.00% |
| Net margin | 0.00% | (87.62%) | 0.00% |
| Free cash flow margin | 0.00% | (43.91%) | 0.00% |
| Return on equity | (38.86%) | (461.65%) | (56.36%) |
| Return on assets | (36.80%) | (51.91%) | (48.04%) |
| Return on invested capital | (40.58%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack